Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
EBOS Group Limited ( (AU:EBO) ) just unveiled an announcement.
EBOS Group Limited announced a change in the director’s interest as Coline McConville acquired 1,000 ordinary shares on the market, valued at A$24,347.20. This acquisition reflects a direct interest and signifies a potential increase in the director’s stake in the company, which may influence stakeholder perceptions and the company’s market positioning.
The most recent analyst rating on (AU:EBO) stock is a Hold with a A$28.00 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.
More about EBOS Group Limited
EBOS Group Limited operates in the healthcare and animal care sectors, providing a wide range of products and services. The company focuses on distributing healthcare, medical, and pharmaceutical products, as well as animal care products, across various markets.
Average Trading Volume: 128,926
Technical Sentiment Signal: Sell
Current Market Cap: A$5.02B
Find detailed analytics on EBO stock on TipRanks’ Stock Analysis page.